References
- Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746–2751. doi:https://doi.org/10.1093/eurheartj/eht280.
- Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129(8):837–847. doi:https://doi.org/10.1161/CIRCULATIONAHA.113.005119.
- January CT, Wann LS, Alpert JS, et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2014;64(21):e1–e76. doi:https://doi.org/10.1016/j.jacc.2014.03.022.
- Ieda M, Fukuda K, Hisaka Y, et al. Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest. 2004;113(6):876–884. doi:https://doi.org/10.1172/JCI200419480.
- Marlin MC, Li G. Biogenesis and function of the NGF/TrkA signaling endosome. Int Rev Cell Mol Biol. 2015;314:239–257. doi:https://doi.org/10.1016/bs.ircmb.2014.10.002.
- Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003;4(4):299–309. doi:https://doi.org/10.1038/nrn1078.
- Snider WD. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell. 1994;77(5):627–638. doi:https://doi.org/10.1016/0092-8674(94)90048-5.
- Bernardo BC, Weeks KL, Pretorius L, et al. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther. 2010;128(1):191–227. doi:https://doi.org/10.1016/j.pharmthera.2010.04.005.
- Matsui T, Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol. 2005;38(1):63–71. doi:https://doi.org/10.1016/j.yjmcc.2004.11.005.
- Tsujita Y, Muraski J, Shiraishi I, et al. Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy. Proc Natl Acad Sci USA. 2006;103(32):11946–11951. doi:https://doi.org/10.1073/pnas.0510138103.
- Kim MS, Shutov LP, Gnanasekaran A, et al. Nerve growth factor (NGF) regulates activity of nuclear factor of activated T-cells (NFAT) in neurons via the phosphatidylinositol 3-kinase (PI3K)-Akt-glycogen synthase kinase 3β (GSK3β) pathway. J Biol Chem. 2014;289(45):31349–31360. doi:https://doi.org/10.1074/jbc.M114.587188.
- Zhao Y, Cui GM, Zhou NN, et al. Calpain-calcineurin-nuclear factor signaling and the development of atrial fibrillation in patients with valvular heart disease and diabetes. J Diabetes Res. 2016;2016:4639654. doi:https://doi.org/10.1155/2016/4639654.
- January CT, Wann LS, Alpert JS, et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the heart rhythm society. Circulation. 2014;130(23):2071–2104. doi:https://doi.org/10.1161/CIR.0000000000000040.
- Fye WB. Tracing atrial fibrillation-100 years. N Engl J Med. 2006;355(14):1412–1414. doi:https://doi.org/10.1056/NEJMp068059.
- Chishaki A, Chishaki H. To know the exact prevalence and prognosis of atrial fibrillation from a clinical survey-comments on the “The Fushimi AF Registry”. J Cardiol. 2013;61(4):304–306. doi:https://doi.org/10.1016/j.jjcc.2013.02.005.
- Chen PS, Chen LS, Fishbein MC, et al. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114(9):1500–1515. doi:https://doi.org/10.1161/CIRCRESAHA.114.303772.
- Hasan W, Smith PG. Modulation of rat parasympathetic cardiac ganglion phenotype and NGF synthesis by adrenergic nerves. Auton Neurosci. 2009;145(1–2):17–26. doi:https://doi.org/10.1016/j.autneu.2008.10.012.
- Miyauchi Y, Zhou S, Miyauchi M, et al. Altered atrial electrical restitution and heterogeneous sympathetic hyperinnervation in hearts with chronic left ventricular myocardial infarction: implications for atrial fibrillation. Circulation. 2003;108(3):360–366. doi:https://doi.org/10.1161/01.CIR.0000080327.32573.7C.
- Li CY, Li YG. Cardiac sympathetic nerve sprouting and susceptibility to ventricular arrhythmias after myocardial infarction. Cardiol Res Pract. 2015;2015:698368. doi:https://doi.org/10.1155/2015/698368.
- Cao JM, Chen LS, KenKnight BH, et al. Nerve sprouting and sudden cardiac death. Circ Res. 2000;86(7):816–821. doi:https://doi.org/10.1161/01.RES.86.7.816.
- Feng N, Huke S, Zhu G, et al. Constitutive BDNF/TrkB signaling is required for normal cardiac contraction and relaxation. Proc Natl Acad Sci USA. 2015;112(6):1880–1885. doi:https://doi.org/10.1073/pnas.1417949112.
- Hou Y, Jia L, Zhang Y, et al. Activation of the NGF/TrkA signaling pathway attenuates diabetic erectile dysfunction. Oncotarget. 2017;8(62):105692–105702. doi:https://doi.org/10.18632/oncotarget.22389.
- Anta B, Martin-Rodriguez C, Gomis-Perez C, et al. Ubiquitin-specific protease 36 (USP36) controls neuronal precursor cell-expressed developmentally down-regulated 4-2 (Nedd4-2) actions over the neurotrophin receptor TrkA and potassium voltage-gated channels 7.2/3 (Kv7.2/3). J Biol Chem. 2016;291(36):19132–19145. doi:https://doi.org/10.1074/jbc.M116.722637.
- Yu T, Calvo L, Anta B, et al. Regulation of trafficking of activated TrkA is critical for NGF-mediated functions. Traffic. 2011;12(4):521–534. doi:https://doi.org/10.1111/j.1600-0854.2010.01156.x.
- Zhang P, Wang W, Wang X, et al. Focal adhesion kinase mediates atrial fibrosis via the AKT/S6K signaling pathway in chronic atrial fibrillation patients with rheumatic mitral valve disease. Int J Cardiol. 2013;168(4):3200–3207. doi:https://doi.org/10.1016/j.ijcard.2013.04.113.
- Wiersma M, Meijering RAM, Qi XY, et al. Endoplasmic reticulum stress is associated with autophagy and cardiomyocyte remodeling in experimental and human atrial fibrillation. J Am Heart Assoc. 2017;6(10):e006458.
- Prévilon M, Pezet M, Dachez C, et al. Sequential alterations in Akt, GSK3β, and calcineurin signalling in the mouse left ventricle after thoracic aortic constriction . Can J Physiol Pharmacol. 2010;88(11):1093–1101. doi:https://doi.org/10.1139/y10-087.
- Cheng SM, Ho TJ, Yang AL, et al. Exercise training enhances cardiac IGFI-R/PI3K/Akt and Bcl-2 family associated pro-survival pathways in streptozotocin-induced diabetic rats. Int J Cardiol. 2013;167(2):478–485. doi:https://doi.org/10.1016/j.ijcard.2012.01.031.
- Dong M, Hu N, Hua Y, et al. Chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3β-dependent inhibition of apoptosis and ER stress. Biochim Biophys Acta. 2013;1832(6):848–863. doi:https://doi.org/10.1016/j.bbadis.2013.02.023.
- Alessi DR. Discovery of PDK1, one of the missing links in insulin signal transduction. Biochem Soc Trans. 2001;29(Pt 2):1–14. doi:https://doi.org/10.1042/bst0290001.
- Vincent EE, Elder DJ, Thomas EC, et al. Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer. Br J Cancer. 2011;104(11):1755–1761. doi:https://doi.org/10.1038/bjc.2011.132.
- Hardt SE, Sadoshima J. Negative regulators of cardiac hypertrophy. Cardiovasc Res. 2004;63(3):500–909. doi:https://doi.org/10.1016/j.cardiores.2004.03.015.
- Thornton TM, Pedraza-Alva G, Deng B, et al. Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science. 2008;320(5876):667–670. doi:https://doi.org/10.1126/science.1156037.
- Matsuda T, Zhai P, Maejima Y, et al. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload. Proc Natl Acad Sci USA. 2008;105(52):20900–20905. doi:https://doi.org/10.1073/pnas.0808315106.
- Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63(22):2335–2345. doi:https://doi.org/10.1016/j.jacc.2014.02.555.